Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis

Brandt-Juergens J, Rudwaleit M, Behrens F, Ritchlin C, Peterlik D, Quebe-Fehling E, Calheiros R, Deodhar A (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2074-2076.

Kurzbeitrag Konferenz / Poster | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Brandt-Juergens, Jan; Rudwaleit, MartinUniBi; Behrens, Frank; Ritchlin, Christopher; Peterlik, Daniel; Quebe-Fehling, Erhard; Calheiros, Renato; Deodhar, Atul
herausgebende Körperschaft
American College of Rheumatology
Erscheinungsjahr
2022
Titel des Konferenzbandes
ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA
Serien- oder Zeitschriftentitel
Arthritis & Rheumatology
Band
74
Ausgabe
Suppl. 9
Seite(n)
2074-2076
ISSN
2326-5191
eISSN
2326-5205
Page URI
https://pub.uni-bielefeld.de/record/2968213

Zitieren

Brandt-Juergens J, Rudwaleit M, Behrens F, et al. Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In: American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. Vol 74. Hoboken: Wiley; 2022: 2074-2076.
Brandt-Juergens, J., Rudwaleit, M., Behrens, F., Ritchlin, C., Peterlik, D., Quebe-Fehling, E., Calheiros, R., et al. (2022). Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In American College of Rheumatology (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 2074-2076). Hoboken: Wiley. https://doi.org/10.1002/art.42355
Brandt-Juergens, Jan, Rudwaleit, Martin, Behrens, Frank, Ritchlin, Christopher, Peterlik, Daniel, Quebe-Fehling, Erhard, Calheiros, Renato, and Deodhar, Atul. 2022. “Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis”. In ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, ed. American College of Rheumatology, 74:2074-2076. Arthritis & Rheumatology. Hoboken: Wiley.
Brandt-Juergens, J., Rudwaleit, M., Behrens, F., Ritchlin, C., Peterlik, D., Quebe-Fehling, E., Calheiros, R., and Deodhar, A. (2022). “Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis” in ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatology ed. Arthritis & Rheumatology, vol. 74, (Hoboken: Wiley), 2074-2076.
Brandt-Juergens, J., et al., 2022. Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In American College of Rheumatology, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. no.74 Hoboken: Wiley, pp. 2074-2076.
J. Brandt-Juergens, et al., “Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis”, ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatology, ed., Arthritis & Rheumatology, vol. 74, Hoboken: Wiley, 2022, pp.2074-2076.
Brandt-Juergens, J., Rudwaleit, M., Behrens, F., Ritchlin, C., Peterlik, D., Quebe-Fehling, E., Calheiros, R., Deodhar, A.: Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis. In: American College of Rheumatology (ed.) ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. 74, p. 2074-2076. Wiley, Hoboken (2022).
Brandt-Juergens, Jan, Rudwaleit, Martin, Behrens, Frank, Ritchlin, Christopher, Peterlik, Daniel, Quebe-Fehling, Erhard, Calheiros, Renato, and Deodhar, Atul. “Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc Analysis”. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Ed. American College of Rheumatology. Hoboken: Wiley, 2022.Vol. 74. Arthritis & Rheumatology. 2074-2076.
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Suchen in

Google Scholar